Thesan Pharmaceuticals (San Clemente, CA), a preclinical biopharmaceutical company focused on dermatological disorders, closed a $16M Series A financing. Participants include Novo Ventures and Novartis Venture Funds.

Collective IP | The Most Comprehensive and Accurate View of Global Innovation and Organization of the International Technology Transfer Office Ecosystem

Request Collective IP Account Access HERE